Although a larger prospective study is warranted to confirm the relationship, surveillance of the development of GO in patients with GD should be considered, particularly for those with obesity-related factors, such as higher fasting plasma insulin and HOMA-IR. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.